Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins

References

• LaughlinRSDyckPJMeltonRJ3rdLeibsonRCRansomJDyckPJIncidence and prevalence of CIDP and the association of diabetes mellitusNeurology200973394519564582
   PubMed Web of Science ®Google Scholar
• RajaballyYASimpsonBSBeriSBankartJGosalakalJEpidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK populationMuscle Nerve20093943243819260065
   PubMed Web of Science ®Google Scholar
• RajaballyYAChavadaGLewis-Sumner syndrome of pure upper limb onset: diagnostic, prognostic and therapeutic featuresMuscle Nerve20093920622019145651
   PubMed Web of Science ®Google Scholar
• SaidGChronic inflammatory demyelinating polyneuropathyNeuromuscul Disord20061629330316631367
   PubMed Web of Science ®Google Scholar
• WaksmanBHAdamsRDA comparative study of experimental allergic neuritis in the rabbit, guinea pig, and mouseJ Neuropathol Exp Neurol19561529333413346395
   PubMed Web of Science ®Google Scholar
• LampertPWMechanism of demyelination in experimental allergic neuritis. Electron microscopic studiesLab Invest1969201271385764785
   PubMed Web of Science ®Google Scholar
• GabrielCMHughesRAMooreSESmithKJWalshFSInduction of experimental autoimmune neuritis with peripheral myelin protein-22Brain1998121189519029798745
   PubMed Web of Science ®Google Scholar
• KadlubowskiMHughesRAIdentification of the neuritogen for experimental allergic neuritisNature1979277140141310522
   PubMed Web of Science ®Google Scholar
• MilnerPLovelidgeCATaylorWAHughesRAP0 myelin protein produces experimental allergic neuritis in Lewis ratsJ Neurol Sci1987792752852440998
   PubMed Web of Science ®Google Scholar
• PollardJDKingRHThomasPKRecurrent experimental allergic neuritis. An electron microscope studyJ Neurol Sci1975243653831117310
   PubMed Web of Science ®Google Scholar
• HarveyGKPollardJDSchindhelmKAntonyJChronic experimental allergic neuritis. An electrophysiological and histological study in the rabbitJ Neurol Sci1987812152253694229
   PubMed Web of Science ®Google Scholar
• BrosnanJVCraggsRIKingRHThomasPKAttempts to suppress experimental allergic neuritis in the rat by pretreatment with antigenActa Neuropathol1984641531606332448
   PubMed Web of Science ®Google Scholar
• AdamAMAtkinsonPFHallSMHughesRATaylorWAChronic experimental allergic neuritis in Lewis ratsNeuropathol Appl Neurobiol1989152492642787483
   PubMed Web of Science ®Google Scholar
• GabrielCMGregsonNAHughesRAAnti-PMP22 antibodies in patients with inflammatory neuropathyJ Neuroimmunol20001041394610713353
   PubMed Web of Science ®Google Scholar
• YanWXArchelosJJHartungHPPollardJDP0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathyAnn Neurol20015028629211558784
   PubMed Web of Science ®Google Scholar
• AllenDGiannopoulosKGrayIAntibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathyJ Peripher Nerv Syst20051017418015958128
   PubMed Web of Science ®Google Scholar
• SanvitoLMakowskaAMahdi-RogersMHumoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy1J Neurol Neurosurg Psychiatry20098033333819015227
   PubMed Web of Science ®Google Scholar
• Melendez-VasquezCRedfordJChoudharyPPImmunological investigation of chronic inflammatory demyelinating polyradiculoneuropathyJ Neuroimmunol1997731241349058768
   PubMed Web of Science ®Google Scholar
• BouchardCLacroixCPlanteVClinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathyNeurology19995249850310025777
   PubMed Web of Science ®Google Scholar
• Khalili-ShiraziAGregsonNALondeiMSummersLHughesRAThe distribution of CD1 molecules in inflammatory neuropathyJ Neurol Sci19981581541639702686
   PubMed Web of Science ®Google Scholar
• KieseierBCDalakasMCHartungHPImmune mechanisms in chronic inflammatory demyelinating neuropathyNeurology200259S7S1212499465
   PubMed Web of Science ®Google Scholar
• Khalili-ShiraziAHughesRABrostoffSWLiningtonCGregsonNT cell responses to myelin proteins in Guillain-Barre syndromeJ Neurol Sci19921112002031279128
   PubMed Web of Science ®Google Scholar
• DyckPJO’BrienPCOviattKFPrednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatmentAnn Neurol1982111361417041788
   PubMed Web of Science ®Google Scholar
• DyckPJDaubeJO’BrienPPlasma exchange in chronic inflammatory demyelinating polyradiculoneuropathyN Engl J Med19863144614653511382
   PubMed Web of Science ®Google Scholar
• HahnAFBoltonCFPillayNPlasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over studyBrain1996119105510668813270
   PubMed Web of Science ®Google Scholar
• MendellJRBarohnRJFreimerMLRandomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathyNeurology20015644544911222785
   PubMed Web of Science ®Google Scholar
• van DoornPABrandAStrengersPFMeulsteeJVermeulenMHigh-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover studyNeurology1990402092122405291
   PubMed Web of Science ®Google Scholar
• ChoudharyPPThompsonNHughesRAImprovement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathyJ Neurol19952422522537798127
   PubMed Web of Science ®Google Scholar
• HaddenRDSharrackBBensaSSoudainSEHughesRARandomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathyNeurology199953576110408537
   PubMed Web of Science ®Google Scholar
• KazatchkineMDKaveriSVImmunomodulation of autoimmune and inflammatory diseases with intravenous immune globulinN Engl J Med200134574775511547745
   PubMed Web of Science ®Google Scholar
• ImbachPBarandunSBaumgartnerCHirtAHoferFWagnerHPHigh-dose intravenous gammaglobulin therapy of refractory, in particular idiopathic thrombocytopenia in childhoodHelv Paediatr Acta19813681866785258
   PubMedGoogle Scholar
• KondoNKasaharaKKameyamaTIntravenous immunoglobulins suppress immunoglobulin productions by suppressing Ca(2+)-dependent signal transduction through Fc gamma receptors in B lymphocytesScand J Immunol19944037428029641
   PubMed Web of Science ®Google Scholar
• StohlWElliotJEIn vitro inhibition by intravenous immunoglobulin of human T cell-dependent B cell differentiation induced by staphylococcal superantigensClin Immunol Immunopathol1996791221338620618
   PubMedGoogle Scholar
• ToungouzMDenysCHDe GrooteDDupontEIn vitro inhibition of tumour necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulinsB J Haematol199589698703
   Web of Science ®Google Scholar
• ToyodaMPaoAPetrosianAJordanSCPooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cellsAm J Transplant2003315616612603211
   PubMed Web of Science ®Google Scholar
• VassilevTGelinCKaveriSVZilberMTBoumsellLKazatchkineMDAntibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)Clin Exp Immunol1993923693727685668
   PubMed Web of Science ®Google Scholar
• YuZLennonVAMechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseasesN Eng J Med199934227228
   Web of Science ®Google Scholar
• SundbladAMarcosMAMalanchereEObservations on the mode of action of normal immunoglobulin at high dosesImmunol Rev19941391251587927409
   PubMed Web of Science ®Google Scholar
• PashovAKaveriAKazatchkineMDBellonBSuppression of experimental autoimmune encephalomyelitis by intravenous immunoglobulinKazatchkineMDMorellAIntravenous Immunoglobulin: Research and TherapyNew YorkParthenon Publishing1996317318
   Google Scholar
• SaoudiAHurezVde KozakYHuman immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitisInt Immunol19935155915678312226
   PubMed Web of Science ®Google Scholar
• BastaMVan GoorFLuccioliSF(ab)’2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulinsNat Med2003943143812612546
   PubMed Web of Science ®Google Scholar
• FrankMMBastaMFriesLFThe effects of intravenous immune globulin on complement-dependent immune damage of cells and tissuesClin Immunol Immunopathol199262S82S861728991
   PubMedGoogle Scholar
• MollnesTEHogasenKHoaasBFMichaelsenTEGarredPHarboeMInhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding propertiesScand J Immunol1995454494567725063
   PubMed Web of Science ®Google Scholar
• DalakasMCMechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathiesNeurology200259S13S2112499466
   PubMed Web of Science ®Google Scholar
• VermeulenMvan der MecheFGSpeelmanJDWeberABuschHFPlasma and gamma-globulin infusion in chronic inflammatory polyneuropathyJ Neurol Sci1985703173262414406
   PubMed Web of Science ®Google Scholar
• FaedJMDayBPollockMTaylorPKNukadaHHammond-TookeGDHigh-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathyNeurology1989394224252927654
   PubMed Web of Science ®Google Scholar
• van DoornPAVermeulenMBrandAMulderPGBuschHFIntravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvementArch Neurol1991482172201847041
   PubMedGoogle Scholar
• CornblathDRChaudhryVGriffinJWTreatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulinAnn Neurol1991301041061929221
   PubMed Web of Science ®Google Scholar
• VermeulenMvan DoornPABrandAStrengersPFJennekensFGBuschHFIntravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled studyJ Neurol Neurosurg Psychiatry19935636398429321
   PubMed Web of Science ®Google Scholar
• HughesRBensaSWillisonHRandomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathyAnn Neurol20015019520111506402
   PubMed Web of Science ®Google Scholar
• DyckPJLitchyWJKratzKMA plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathyAnn Neurol1994368388457998769
   PubMed Web of Science ®Google Scholar
• EftimovFWinerJBVermeulenMdeHRvanSI. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathyCochrane Database Syst Rev2009CD00179719160200
   PubMed Web of Science ®Google Scholar
• HughesRADonofrioPBrilVIntravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trialLancet Neurol2008713614418178525
   PubMed Web of Science ®Google Scholar
• RajaballyYASeowHWilsonPDose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathyJ Peripher Nerv Syst20061132532917117941
   PubMed Web of Science ®Google Scholar
• GajdosPTranchantCClairBTreatment of myasthenia gravis exacerbations with intravenous immunoglobulin: a randomized double-blind clinical trialArch Neurol2005621689169316286541
   PubMed Web of Science ®Google Scholar
• RMC trialRandomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre studyLancet Neurol2009815816419136303
   PubMed Web of Science ®Google Scholar
• GorsonKHughesRCrosDEfficacy of interferon beta-1a in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)Neurology200870suppl 1A369
   Google Scholar
• Mahdi-RogersMHughesRACMcCronePEconomic costs of chronic inflammatory demyelinating radiculoneuropathy, multifocal motor neuropathy and paraproteinaemic demyelinating neuropathyJ Peripher Nervous Syst200914s29495
   Google Scholar
• VucicSBlackKBaldassariLESiao TickChong PDawsonKTLong-term effects of intravenous immunoglobulin in CIDPClin Neurophysiol20071181980198417604689
   PubMed Web of Science ®Google Scholar
• BorteMBernatowskaEGardulfAEfficacy and safety of vivaglobin applied subcutaneously to patients with primary immune deficiency (PID)Interim analysis after more than 1300 Infusions. European Society for Immunodeficiencies (ESID) Weimar. 2002.
   Google Scholar
• OchsHDGuptaSKiesslingPNicolayUBergerMSafety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseasesJ Clin Immunol20062626527316783465
   PubMed Web of Science ®Google Scholar
• LeeDHLinkerRAPaulusWSchneider-GoldCChanAGoldRSubcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathyMuscle Nerve20083740640917918749
   PubMed Web of Science ®Google Scholar
• KollerHSchroeterMFeischenHHartungHPKieseierBCSubcutaneous self-infusions of immunoglobulins as a potential therapeutic regimen in immune-mediated neuropathiesJ Neurol20062531505150616972122
   PubMed Web of Science ®Google Scholar
• CocitoDPaolassoIAntoniniGA nationwide retrospective analysis on the effect of immune therapies in patients with chronic demyelinating inflammatory polyradiculoneuropathyEur J Neurol2009 [Epub ahead of print].
   Google Scholar
• IijimaMTomitaMMorozumiSSingle nucleotide polymorphism of TAG-1 influences IVIg responsiveness of patients with CIDPNeurology2009731348135219776380
   PubMed Web of Science ®Google Scholar